Home
Stewards of critical care
FOCUS
Addressing urgent needs
We are uniquely positioned to combat serious conditions and advance innovative treatment options in areas of high unmet need
Critical Care
Infectious Diseases
Global Mission
Our products
GIAPREZA®
(angiotensin II)
A vasoconstrictor to increase blood pressure in adults with septic or other distributive shock
In partnership with
VISIT GIAPREZA.COM
XERAVA®
(eravacycline)
An antibiotic indicated for the treatment of complicated intra-abdominal infection caused by susceptible microorganisms
VISIT XERAVA.COM
XACDURO®
(sulbactam for injection; durlobactam for injection), co-packaged for intravenous use
For the treatment of hospital-acquired/ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter
VISIT XACDURO.COM
Development pipeline
Product
Phase 1
Phase 2
Phase 3
Review
Approval
ZOLIFLODACIN
Company
An enduring influence
A growing and diversified biopharmaceutical company, we are building a culture dedicated to delivering products that save lives
Leadership
Led by a mission-driven team that blends rigorous medical science with the latest advances in pharmaceutical innovation
Learn More
Careers
Join a team where all colleagues can do their best work while making a lasting impact
Learn More